Happy Holidays
Click to view our 2016 Holiday Card
HOME
ABOUT US
DAIICHI SANKYO
NEWS
CAREER
OPPORTUNITIES
CONTRACT MANUFACTURING
SERVICES
CONTACT US

Contact Us

Luitpold Pharmaceuticals, Inc. │ American Regent, Inc. │ Luitpold Animal Health Osteohealth Company  │ Contract Manufacturing

 

Mailing Address

One Luitpold Drive
P.O. Box 9001
Shirley, NY 11967
Get Directions
Phone
Fax
Email
(631) 924-4000
(631) 924-1731
inquiry@luitpold.com

 

 

Customer Service (8:30 AM-6 PM eastern time, Monday through Thursday)

(8:30 AM-5 PM eastern time, Friday)
(800) 645-1706 (American Regent, Inc.)
(800) 458-0163 (Animal Health)
(800) 874-2334 (Osteohealth Company)


24 hour emergency drug information: (877) 845-6371


Venofer® Iron Sucrose Injection, USP Reimbursement Hotline and Patient Assistance Program

(800) 282-7712 (9 AM-5 PM, Eastern Time)

 

To Report Adverse Drug Events (ADEs):

(American Regent, Inc., Animal Health and Osteohealth Company)

Email: pv@luitpold.com

Fax: 610-650-0170

Phone: 800-734-9236

Or

Submit the Adverse Drug Events Report Form: Adverse Drug Event Form

and Email it to: pv@luitpold.com

 

To report a Product Quality Complaint:

(to any products from American Regent, Inc., Animal Health and Osteohealth Company)

please call toll-free: 1-888-354-4859

Or

Email: pqc@luitpold.com

 


DAIICHI SANKYO NAMES NEW PRESIDENT OF US SUBSIDIARY LUITPOLD PHARMACEUTICALS, INC.

June 29, 2016 – Effective today, Ken Keller has been newly appointed as President and CEO of Luitpold Pharmaceuticals, in addition to his current position as President, Daiichi Sankyo Administrative and Commercial, Daiichi Sankyo, Inc.

With more than 25 years of experience in the pharmaceutical industry in commercial leadership and joint venture leadership, Mr. Keller will now oversee both the Daiichi Sankyo, Inc. Commercial organization and Luitpold Pharmaceuticals, Inc.

Mr. Keller joined Daiichi Sankyo, Inc. in 2014 and has also served on the Luitpold Board of Directors since 2015. He has successfully led the Daiichi Sankyo, Inc. US commercial organization as it begins its transformation to a specialty focused company.

“While Luitpold and Daiichi Sankyo US businesses serve different customers and markets, they each bring to the table important strengths and focus that are essential to the continued success and growth of the Daiichi Sankyo Group,” said Ken Keller. “I look forward to working with the Luitpold team and driving even further success in the future.”

Luitpold Pharmaceuticals, Inc. is a Daiichi Sankyo Group Company headquartered in Shirley, NY, and manufactures more than 80 pharmaceutical products.